Both the CMV-DP and CMV-DN cohorts showed a trend in which HLA-mismatched donor groups (Young78 and Old78) had more patients receiving total body irradiation, T-cell depletion, and PBSCs than those in HLA-matched groups (Young88 and Old88).
← all excerpts
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT.
1
—
—